Could a simple drug shorten labor? new trial tests papaverine
NCT ID NCT07237880
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a single dose of papaverine, a muscle relaxant, can safely shorten the second stage of labor in pregnant women who had a balloon catheter to start labor. Researchers will compare labor times and outcomes between women who get papaverine and those who get a placebo. The trial aims to find a simple way to reduce labor duration and improve the birth experience.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
papaverine
What this could lead to
If it works, this could offer a simple, safe way to shorten labor for women after cervical ripening, potentially reducing discomfort and complications.
What could go wrong
This is an early-stage trial with only 184 participants. The drug may not shorten labor significantly, and there is a small risk of side effects like allergic reactions or effects on the baby.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LABOR, INDUCED are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hillel Yaffe Medical Center
RECRUITINGHadera, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••